返回
Jiangsu Recbio Technology Co., Ltd.（02179.HK）价格
02179.HK 股价走势图
RECBIO-B (02179.HK)
Jiangsu Recbio Technology Co., Ltd.
HK$5.7
3.63%
$0.2
休市： Jan 16, 16:00:00 HKT
暂无数据Earnings FAQ
02179.HK 最近的每股收益与预期相比如何？
Jiangsu Recbio Technology Co., Ltd. 02179.HK 上一季度的收入表现如何？
Jiangsu Recbio Technology Co., Ltd. 的收入预期是多少？
Jiangsu Recbio Technology Co., Ltd. 的盈利质量评分是多少？
Jiangsu Recbio Technology Co., Ltd. 何时发布财报？
Jiangsu Recbio Technology Co., Ltd. 的预期收益是多少？
Jiangsu Recbio Technology Co., Ltd. 是否超出收益预期？
关键数据
前收盘价
$5.48
开盘价
$5.5
当日区间
$5.48 - $5.7
52周范围
$3.4 - $9.8
交易量
11.5K
平均成交量
44.4K
每股收益（TTM）
-1.51
股息收益率
--
市值
$1.8B
什么是 RECBIO-B？
Jiangsu Recbio Technology Co., Ltd. engages in the research and development of vaccines. The company is headquartered in Taizhou, Jiangsu and currently employs 507 full-time employees. The company went IPO on 2022-03-31. The firm is still in the research and development stage. The firm's vaccine pipeline includes recombinant human papillomavirus (HPV) 9-valent vaccine, novel adjuvanted recombinant HPV 9-valent vaccine, recombinant HPV bivalent (Types 16/18) vaccine, recombinant HPV bivalent (Types 6/11) vaccine, novel adjuvanted recombinant HPV quadrivalent vaccine, novel adjuvanted recombinant shingles vaccine, novel adjuvanted recombinant respiratory syncytial virus vaccine, recombinant metapneumovirus vaccine, recombinant human cytomegalovirus vaccine, recombinant bicomponent COVID-19 vaccine, recombinant hepatitis B virus vaccine, and others.